期刊
FUTURE MEDICINAL CHEMISTRY
卷 15, 期 5, 页码 405-419出版社
Newlands Press Ltd
DOI: 10.4155/fmc-2022-0306
关键词
diabetics II inhibitors; enzymatic kinetics study; new pyrrolopyridine-based thiazolotriazole
Aim: The aim of this study was to synthesize pyrrolopyridine-based thiazolotriazoles as a novel class of alpha-amylase and alpha-glucosidase inhibitors and determine their enzymatic kinetics. Methodology: Pyrrolopyridine-based thiazolotriazole analogs (1-24) were synthesized and characterized through various spectroscopic techniques. Results: The synthesized analogs exhibited significant inhibitory potential against alpha-amylase and alpha-glucosidase, with analog 3 showing the highest inhibitory activity. The structure-activity relationship and binding modes of interactions were confirmed through docking and enzymatic kinetics studies. The compounds (1-24) showed no cytotoxicity against the 3T3 mouse fibroblast cell line.
Aim: To synthesize pyrrolopyridine-based thiazolotriazoles as a novel class of alpha-amylase and alpha-glucosidase inhibitors and to determine their enzymatic kinetics. Methodology: Pyrrolopyridine-based thiazolotriazole analogs (1-24) were synthesized and characterized through proton nuclear magnetic resonance, carbon-13 nuclear magnetic resonance and high-resolution electron ionization mass spectrometry. Results: All synthesized analogs displayed good inhibitory potential of alpha-amylase and alpha-glucosidase ranging 17.65-70.7 mu M and 18.15-71.97 mu M, respectively, compared with the reference drug, acarbose (11.98 mu M and 12.79 mu M). Analog 3 was the most potent among the synthesized analogs, having alpha-amylase and alpha-glucosidase inhibitory activity at 17.65 and 18.15 mu M, respectively. The structure-activity relationship and binding modes of interactions between selected analogs were confirmed via docking and enzymatic kinetics studies. The compounds (1-24) were tested for cytotoxicity against the 3T3 mouse fibroblast cell line and were observed to be nontoxic.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据